(EMO) ClearBridge Energy MLP - Ratings and Ratios
Energy, Infrastructure, Pipelines, Storage, Transportation
Dividends
| Dividend Yield | 11.10% |
| Yield on Cost 5y | 46.92% |
| Yield CAGR 5y | 30.81% |
| Payout Consistency | 90.5% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 18.8% |
| Value at Risk 5%th | 31.2% |
| Relative Tail Risk | 0.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -9.54 |
| CAGR/Max DD | 1.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.381 |
| Beta | 0.674 |
| Beta Downside | 0.995 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.81% |
| Mean DD | 4.34% |
| Median DD | 3.46% |
Description: EMO ClearBridge Energy MLP December 29, 2025
ClearBridge Energy MLP Opportunity Closed Fund (NYSE: EMO) is a U.S.-based closed-end fund that focuses on Energy Limited Partnership securities, aiming to deliver high current income through investments in midstream energy infrastructure.
Recent fund metrics (Q3 2024) show an annualized distribution yield of roughly 8.5%, a net asset value (NAV) per share near $10.2, and a leverage ratio of about 30%, aligning with the fund’s stated risk parameters. Performance is heavily influenced by natural-gas pipeline utilization rates, which have risen ~4% year-over-year, and by the spread between natural-gas and crude-oil prices-both key drivers of cash flow for the underlying MLPs.
Critical macro-level drivers to watch include Federal Energy Regulatory Commission (FERC) pipeline approval pipelines, U.S. natural-gas inventory trends, and broader energy demand forecasts, as shifts in any of these can materially affect the fund’s income stability.
For a deeper, data-rich breakdown of EMO’s holdings and risk profile, the ValueRay platform offers an interactive dashboard that can help you validate these assumptions.
What is the price of EMO shares?
Over the past week, the price has changed by -0.67%, over one month by -0.95%, over three months by +2.59% and over the past year by +3.43%.
Is EMO a buy, sell or hold?
What are the forecasts/targets for the EMO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 59.3 | 33.6% |
EMO Fundamental Data Overview January 07, 2026
Beta = None
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 395.6m USD (395.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 395.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 395.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.50% (E(395.6m)/V(395.6m) * Re(8.50%) + (debt-free company))
Discount Rate = 8.50% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for EMO Fund
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle